Adze Biotechnology
Developer of oncologic immunotherapies designed to help in the treatment of cancers with significant unmet needs. The company's immunotherapies harness immune response mechanisms and target immune sti...
Valuation
$0
Share Price
N/A
Total Raised
$9.8M
Last Round
N/A